Alec van Gelder/LinkedIn
Dec 5, 2025, 06:04
Alec van Gelder: Expanding Global Support for People with Blood Disorder
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared on LinkedIn:
“Congratulations to the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation as you expand your reach to support even more people living with haemophilia, sickle cell disease, and thalassaemia. Wishing the NNHF Council and team continued success as you amplify your impact and shape a brighter future for patients and communities living with blood disorders worldwide.”
Stay informed with Hemostasis Today.
-
Jan 22, 2026, 15:36We Must Roll Up Our Sleeves And Help: José Antonio García Erce on Plasma Donation
-
Jan 22, 2026, 15:25Nita Radhakrishnan on Challenges In Congenital Afibrinogenemia
-
Jan 22, 2026, 15:10Jin Q Gives a Summary of 2025’s Most Impactful Cell and Gene Therapy Milestones
-
Jan 22, 2026, 14:57Nirav Dhanesha on CD14 Acting As A Functional Driver of DVT
-
Jan 22, 2026, 11:41Jamilla Goedegebuur and Colleagues on VTE Management in Case of PAD
-
Jan 22, 2026, 11:28Abdulrahman Katib on API-CAT Trial’s Evaluation of Apixaban Dosing
-
Jan 22, 2026, 11:19Bruno Odisio: Ablation Margins Are Software-Dependent
-
Jan 22, 2026, 10:38Pedro Perez: The VTE Market Is Clearly Entering Its Next Phase
-
Jan 22, 2026, 10:29Marvin Garcia Reyes Presents a Case of Aorto-Visceral and Aorto-Iliac Thrombosis